National Stock Exchange of India structured its Rs 22,562 crore IPO entirely as an offer for sale with zero fresh issue. This wasn't a constraint—it was a choice born from exceptional financial strength. NSE carries no debt, maintains positive cash balances, and generates sufficient liquidity to fund its operations for the next 12 months without external capital. The company's consistent cash generation enables it to self-fund investments while maintaining a high-quality capital buffer. DRHP +2
This approach contrasts sharply with BSE's 2025 listing, where the exchange raised Rs 4,010 crore through a fresh capital component.
The company continues investing heavily in technology—IT capex reached Rs 4,220 crore in FY26 and technology expenses grew to Rs 13,146 crore—using internal resources rather than IPO proceeds. DRHP +2
Life Insurance Corporation of India enters this IPO with an already massive exposure. LIC holds 265.3 million shares representing a 10.72% pre-IPO stake, making it NSE's largest shareholder. The anchor allocation added another Rs 450-500 crore through three LIC entities—LIC itself, LIC Mutual Fund, and LIC Pension Fund. DRHP +1
This creates significant concentration risk. LIC's existing stake alone is larger than the entire IPO offer size. The exchange business faces substantial volatility from trading volume dependence and regulatory changes. NSE's equity options market share has already declined from 96.86% in FY24 to 74.71% in FY26 due to SEBI measures. LIC's board representation rights through nominee directors provide some governance influence, but the insurer's fortunes are now heavily tied to exchange sector performance. DRHP +2
The SBI group executed a sophisticated dual strategy. State Bank of India and SBI Capital Markets are selling up to 1% of their combined NSE holding—SBI offloading 0.65% and SBI Capital Markets 0.35%. Yet simultaneously, other SBI group entities invested over Rs 400 crore as anchor investors through SBI Mutual Fund, SBI General, SBI Life, and SBI Pension Fund.
The math behind this move is compelling.
The group maintains substantial exposure with a combined pre-offer stake of approximately 7.89% across SBI, SBI Capital Markets, and SBI Life. Regulatory restrictions prevent SBI Capital Markets from acting as a full merchant banker due to its association with a selling shareholder, limiting it to marketing activities only. DRHP +5
Several factors explain this gap.
NSE's profitability metrics trail BSE's. BSE delivers a superior return on net worth of 45% compared to NSE's 33.21%, along with higher book value per share. More critically, NSE's recent financial performance raised concerns. Profit declined 12.29% in FY26 to Rs 10,302 crore from Rs 12,188 crore in FY25, while operating EBITDA margins compressed to 66.85% from 73.78%. DRHP +2
Regulatory headwinds weigh heavily. SEBI's measures between October 2024 and May 2025—mandatory upfront option premium collection, increased minimum contract sizes, and weekly expiry restrictions—have already eroded NSE's market share. The exchange's revenue concentration creates additional vulnerability. Approximately 79% of revenue comes from transaction charges, with options alone contributing 60.22%. This trading-linked revenue model makes earnings highly sensitive to market volumes and regulatory changes. DRHP +1
This disconnect reveals different investor horizons and risk appetites.
Institutional investors focus on long-term value. The anchor book attracted Rs 6,746 crore from 189 investors, with foreign portfolio investors accounting for 43% of allocations. Sovereign wealth funds including Singapore's GIC, Abu Dhabi Investment Authority, and Norway's Norges Bank participated, signaling global confidence in Indian market infrastructure. Domestic institutions committed 53% of the anchor book through 29 mutual funds and 11 insurance and pension companies.
Retail investors, however, faced different considerations. The Rs 22,562 crore issue size required substantial capital allocation even with the minimum investment of Rs 14,280 per lot. The pure OFS structure meant no growth capital for NSE, while rich valuations at 42.9x earnings and declining grey market premiums from an initial 17% to just 2-3% dampened enthusiasm for quick listing gains.
SEBI's Regulation 45 of the SECC Regulations 2018 explicitly prohibits recognized stock exchanges from listing their own securities on their platforms. This structural separation addresses five critical conflict-of-interest concerns: surveillance independence, enforcement impartiality, information advantage, price discovery integrity, and investor confidence.
The regulation creates three distinct categories: stock exchanges becoming listed (permitted), stock exchanges listing themselves (prohibited), and stock exchanges listing on other recognized exchanges (permitted). Consequently, NSE must list on BSE despite dominating trading volumes, while BSE enjoys the strategic advantage of self-listing on NSE.
This constraint impacts NSE's listing fee revenue potential. Listing services contribute only 2.12% of NSE's total revenue, so the foregone opportunity cost is relatively small. However, the strategic limitation is significant—BSE controls NSE's listing platform, creating potential leverage that NSE cannot reciprocate. DRHP
NSE shares will also trade on Metropolitan Stock Exchange of India (MSEI) under a "Permitted to Trade" category alongside the BSE listing. This provides MSEI with immediate visibility and a potential liquidity injection, but the competitive impact appears limited.
MSEI faces structural barriers that NSE listing cannot overcome. The exchange is loss-making with revenue of only Rs 3.38 crore in FY26, compared to NSE's Rs 166,013 crore. Stock exchanges exhibit powerful network effects—more traders create better prices, which attracts more traders—making it extremely difficult for third exchanges to gain traction. MSEI's earlier avatar as MCX-SX struggled despite having technology and regulatory approval, eventually filing a competition case against NSE that remains unresolved after a decade.
For NSE, dual listing offers broader market coverage and multiple liquidity sources, but operational complexity and the "Permitted to Trade" status limitations offset some benefits. Price differences between BSE and MSEI may create arbitrage opportunities initially, but transaction costs of approximately 0.1% per round trip will likely eliminate most arbitrage profits as market efficiency improves.
The NSE IPO represents a fascinating case study in market dynamics. Strong institutional demand from sovereign wealth funds and domestic institutions validates the exchange's dominant market position and long-term growth prospects. Yet retail caution reflects appropriate concerns about valuation, regulatory risks, and the absence of growth capital.
The exchange's ability to maintain its market leadership while navigating SEBI's evolving regulatory framework will determine whether the current valuation discount to BSE narrows over time. For now, NSE's listing marks not just a capital market event, but a milestone in India's financial infrastructure development—with all the strategic complexities that entails.
